Prevalence & significance of hepatitis C virus (HCV) seropositivity in blood donors. Thakral B(1), Marwaha N, Chawla YK, Saluja K, Sharma A, Sharma RR, Minz RW, Agnihotri SK. Author information: (1)Departments of Transfusion Medicine, Postgraduate Institute of Medical Education & Research, Chandigarh, India .2 Several epidemiological studies in different contexts have identified at-risk populations with a higher prevalence of HCV infection than the general population.3 Injecting drug users are known to be the population most at risk of HCV infection, with a prevalence estimated between 60% and 80%.4, 5 The. Background: Hepatitis C virus (HCV) infection is a global public health problem and is a leading cause of morbidity and death, with regional variations in genotype prevalence. Objectives: This study aimed to explore the prevalence of anti-HCV seropositivity among patients with hereditary anemias, the association of anti-HCV seropositivity with selected risk factors and the common HCV genotypes. Patients and Methods: This prospective descriptive study was carried out on patients with. Background . We tested the prevalence and impact of HCV seropositivity among Egyptian patients referred for coronary angiography. Subjects and Methods . This cross-sectional study was conducted in Zagazig University hospitals including 509 patients scheduled for elective coronary angiography between June 2013 and June 2014. By taking full history on admission, laboratory workup including HCV. and HCV infections require continuous monitoring as well as evaluation of prevention and surveillance strategies. Current Prevalence of HBV and HCV Seropositivity: The Initiative for Attentiveness and Deterrence of Viral Hepatitis in the Qassim Region of Saudi Arabia Ahmed N Aljarbou* College of Pharmacy, Qassim University, Buraidah, Saudi Arabi
Chronic hepatitis C virus (HCV) infection is a major global health problem affecting 1% of the world population. 1,2 The Sustainable Development Goals that were adopted by the United Nations. Hepatitis C is an infectious disease caused by the hepatitis C virus (HCV) that primarily affects the liver; it is a type of viral hepatitis. During the initial infection people often have mild or no symptoms. Occasionally a fever, dark urine, abdominal pain, and yellow tinged skin occurs A hepatitis C-vírus kisméretű, burokkal rendelkező, egyszálú, pozitív irányú RNS-vírus. A Flaviviridae családon belül a Hepacivirus nemzetségbe tartozik. Hét főbb HCV genotípust különböztetünk meg. Az Egyesült Államokban az esetek 70%-át az 1-es, 20%-át a 2-es, 1%-át pedig a többi genotípus okozza. Az 1-es genotípus úgyszintén a leggyakoribb Dél-Amerikában és. A HCV RNS vírus, emiatt a vírus termelődése során kialakuló mutációk eredményeképp alapvető heterogenitást mutat, 6 eltérő genotípust, számos altípust és vírus variánst írtak le. A betegség súlyosságát és a kezelést jelentősen befolyásolhatja, hogy melyik genotípussal történt fertőzés
The prevalence of HCV seropositivity was 20.4-fold higher in men compared to women. The male/female ratio was 1.18 for HBV. Statistical analysis of the resultant data with chi-square test and Fisher's exact test showed that there is a significant correlation between marital status and HCV seropositivity (value < 0.01). The contamination rate was higher in singles Determinants of intrafamilial HCV transmission are still being debated. The aim of this study is to investigate the correlates of HCV seropositivity among familial contacts of HCV positive patients in Italy. A cross-sectional study was conducted with 175 HCV positive patients (index cases), recruited from Policlinico Gemelli in Rome as well as other hospitals in Central Italy between 1995 and. Anti-hepatitis C virus (HCV) antibody seropositivity is independently associated with poor prognosis in hemodialysis (HD) patients. However, anti-HCV antibody cannot distinguish between patients with active infection and those who have recovered from infection. We therefore aimed in this study to ex Hepatitis C virus (HCV) infection is a major public health concern with an estimated infected population of 130-170 million people worldwide 1 causing approximately 350 000 deaths each year. 2 Several epidemiological studies in different contexts have identified at-risk populations with a higher prevalence of HCV infection than the general.
Abstract <p>Abstract</p> <p>Background</p> <p>Determinants of intrafamilial HCV transmission are still being debated. The aim of this study is to investigate the correlates of HCV seropositivity among familial contacts of HCV positive patients in Italy.</p> <p>Methods</p> <p>A cross-sectional study was conducted with 175 HCV positive patients (index cases), recruited from Policlinico Gemelli. Correlates of HCV seropositivity among familial contacts of HCV positive patients BMC Public Health , Sep 2006 Giuseppe La Torre , Luca Miele , Alice Mannocci , Giacomina Chiaradia , Filippo Berloco , Maria L Gabrieli , Giovanni Gasbarrini , Maria Ficarra , Antonio Matera , Gualtiero Ricciardi , et al
BackgroundDeterminants of intrafamilial HCV transmission are still being debated. The aim of this study is to investigate the correlates of HCV seropositivity among familial contacts of HCV positive patients in Italy.MethodsA cross-sectional study was conducted with 175 HCV positive patients (index cases), recruited from Policlinico Gemelli in Rome as well as other hospitals in Central Italy. Background Determinants of intrafamilial HCV transmission are still being debated. The aim of this study is to investigate the correlates of HCV seropositivity among familial contacts of HCV positive..
The aim of this study was to determine the seropositivity of Hepatitis B virus (HBV) and Hepatitis C virus (HCV) dual infection among blood donors in Nyala Teaching Hospital, which is the biggest (400 beds) hospital in great Dar Fur of Western Sudan. 400 blood donors were tested serologically for the detection of HBsAg and anti-HCV antibodies. Only one (0.25%) out of the 400 examined blood. Outcome variable i. e. HCV seropositivity was determined in laboratory with third generation ELISA technique. All data were entered and analyzed using SPSS Version 20.0 Results The mean age of study population was 39.32 +/- 13.212 years. On analysis of demographics data it was observed that 25 [30.5%] were below 30 years of age and 57 [69.5%. In most studies, the prevalence of HCV seropositivity was approximately 30-40%. The most important source of the extreme heterogeneity among studies was the diverse proportion of IDU. The risk of testing positive for HCV was three times higher for inmates with tattoos, compared with those without tattoo
California Fatal Opioid Overdose and HIV or Hepatitis C Virus (HCV) Vulnerability Assessment HIV, Hepatitis C, & Opioid Overdose Resources (PDF) If you are having difficulty accessing any documents on this page, please contact CDPH at (510) 620-3400 or firstname.lastname@example.org to request this information in an alternate format . Prevalence and Determinants of Anti-HCV Seropositivity and of HCV Genotype among Intravenous Drug Users in Berlin. Scandinavian Journal of Infectious Diseases: Vol. 27, No. 4, pp. 331-337 Objectives. —To determine the risk of heterosexual transmission of hepatitis C virus (HCV) and to identify other risk factors for HCV seropositivity in heterosexual couples. Design. —Retrospective cross-sectional study comparing HCV-seropositive and HCV-seronegative heterosexual men and women. Setting. —Couples recruited from the community and screened for participation in a study of the. Abstract Background Hepatitis C virus (HCV) is a major cause of acute and chronic hepatitis in the United States and abroad. HCV antibody prevalences ranging from 10 to 90% have been reported in intravenous drug abusers, hemodialysis patients, and persons suffering from other liver diseases, whereas HCV seropositivity rates for volunteer blood donor populations are generally under 1%
HCV seropositivity measured with ELISA test • A self administered questionnaire to collect socio-demographic data and risk factors • Medical questionnaire filled in by the physician including the result of HCV testing and possible co-infections with HIV or HBV. • A propensity score method to ensure that the general an . Among patients younger than 70 years, a positive HCV test result remained significantly associated with higher risk for developing ESRD after adjustment for patient characteristics
HCV seropositivity in patients with lichen planus Introduction Lichen planus (LP) is a common inflammatory disorder that affects the skin, mucous membranes, nails and hair. The skin lesions appear as plane-topped, purple, pruritic, polygonal, papules and plaques. Mucosae of mouth, genitalia, esophagus, conjunctiva,. Abstract. Few population-based studies have assessed awareness of hepatitis C virus (HCV) seropositivity and chronic infection. We report awareness of HCV seropositivity and chronic infection and correlates of awareness in a multi-city (Bronx, Miami, Chicago, and San Diego) community-dwelling population sample of United States (US) Hispanics/Latinos recruited during 2008-2011
Hepatit C är en infektion som primärt drabbar levern.Sjukdomen orsakas av hepatit C-viruset (HCV).  Hepatit C ger ofta inga symptom, men en kronisk infektion kan leda till ärrbildning i levern och efter många år till skrumplever.I vissa fall har patienter med skrumplever också leversvikt, levercancer, eller mycket svullna vener i matstrupen och magen, vilket kan leda till att man. We studied the usefulness of the recently designed Trak-C assay for the detection and quantification of the hepatitis C virus (HCV) core antigen (Ag) for the screening of HCV infection in 4,201 subjects selected from 74,150 consecutive volunteers undergoing routine medical checkups. Subjects were selected for screening because they had risk factors (group II, n = 321) and/or elevated alanine. Forty one [41%] patients with LP were anti HCV antibody seropositive. Out of 14 patients, 25 males [43%] and 16 females [38.9%] showed anti HCV antibody seropositivity. It is observed that a definite association exists between LP and HCV infection. Therefore, it is important for a clinician to actively look for HCV infection in all patients with L Table 2 displays HIV and HCV risk behaviors found in the study population and univariate analyses for HCV seropositivity. A significantly higher proportion of IDUs in Lahore versus Quetta had injected drugs in the past 6 months (97.3% versus 67.7%, p < 0.001), of whom most were injecting daily (89.9% versus 67.7%, p < 0.001)
Using data from a cross-sectional study conducted in centres for HCV testing in southeastern France, we aimed to compare the patterns of risk factors in HCV-positive inmates with those in the general population.26 centres for HIV/HCV testing in southeastern France (23 in the general population and 3 in prison).HCV seropositivity measured with. Since its discovery in 1989, hepatitis C virus (HCV) has represented a major cause of chronic liver disease worldwide. The most recent WHO estimate of the prevalence of HCV infection is 2%, representing 123 million people. HCV is the leading cause Objectives To determine the frequency of HCV seropositivity in patients diagnosed with lichen planus (LP). Methods This cross-sectional study was conducted in the Department of Dermatology Unit-II, Mayo Hospital, and Lahore. Sera of 100 patients of LP diagnosed clinically and by histopathology in doubtful cases were assessed for HCV seropositivity. The patients were screened for the presence. llection activities. Design and methods:A cross-sectional study was carried out in 2004, in which all adult residents in four villages in rural Shanxi Province were invited for a questionnaire interview and testing of HIV and HCV antibodies. Results:Of 3062 participating villagers, 29.5% reported a history of selling whole blood or plasma. HIV seropositivity was confirmed in 1.3% of subjects.
Correlates of HCV seropositivity among familial contacts of HCV positive patients. Giuseppe La Torre, Luca Miele, Alice Mannocci, Giacomina Chiaradia, Filippo Berloco, Maria L. Gabrieli, Giovanni Gasbarrini, Maria Giovanna Ficarra, Antonio Matera, Gualtiero Ricciardi, Antonio Grieco IL-28B genetic variation, gender, age, jaundice, hepatitis C virus genotype, and hepatitis B virus and HIV co-infection in spontaneous clearance of hepatitis C virus Conclusion: A frequency of 4.3% for HCV seropositivity was observed in our cohort of male individuals from Okara garrison and the surrounding areas Supporting: 5, Disputing: 3, Mentioning: 39 - A cross-sectional study was carried out to identify risk factors for seropositivity for antibodies against hepatitis C virus (HCV) and to assess to the distribution and determinants of HCV genotypes among intravenous drug users (IVDUs). The study population consisted of 405 IVDUs. Serum specimens were tested for seromarkers for HCV, for human.
HBV and HCV Epidemiology in Israel • Epidemiological data of hepatitis B and hepatitis C virus infection in Israel is limited as large population-based studies have not been performed so far. • The aim of these studies was to collect epidemiological, comorbidities and natural history - data of HBV and HCV infection in the larges Hepatitis C is a chronic liver disease caused by the hepatitis C virus. After exposure, it takes a week or two before there are enough virus particles to be detected in your blood.. Your body. OBJECTIVES. To determine the risk of heterosexual transmission of hepatitis C virus (HCV) and to identify other risk factors for HCV seropositivity in heterosexual couples. DESIGN. Retrospective cross-sectional study comparing HCV-seropositive and HCV-seronegative heterosexual men and women. SETTING. Couples recruited from the community and screened for participation in
Few population-based studies have assessed awareness of hepatitis C virus (HCV) seropositivity and chronic infection. We report awareness of HCV seropositivity and chronic infection and correlates of awareness in a multi-city (Bronx, Miami, Chicago, and San Diego) community-dwelling population sample of United States (US) Hispanics/Latinos recruited during 2008-2011 Linear mixed models were used to evaluate the independent effect of HCV seropositivity on eGFR over time, adjusting for demographic factors, comorbid conditions, illicit drug use, measures of HIV disease status, use of medications, and interactions with baseline low eGFR (<60 mL/min/1.73 m 2). Results: Of 2,684 HIV-infected women, 952 (35%. In Rawalpindi, HCV seropositivity was detected in 60% of chronic active hepatitis cases 16.6% cirrhosis and only 6.6% in hepatocellular carcinoma 22. Therefore, in Hazara Division the seropositivity for anti HCV antibodies in chronic liver disease is similar to other areas of Pakistan Hepatitis C seropositivity is not a risk factor for sensory neuropathy among patients with HI
View Academics in seropositivity of HCV on Academia.edu Information about the open-access article 'Correlates of HCV seropositivity among familial contacts of HCV positive patients' in DOAJ. DOAJ is an online directory that indexes and provides access to quality open access, peer-reviewed journals Hepatitis C virus (HCV) is a globally prevalent pathogen and a leading cause of death and morbidity. 1 The most recent estimates of disease burden show an increase in seroprevalence over the last 15 years to 2.8%, equating to >185 million infections worldwide. 2 Persistent HCV infection is associated with the development of liver cirrhosis, hepatocellular cancer, liver failure, and death, 3. Conclusion We conclude that donor hepatitis-C virus seropositivity is an independent risk factor for increased mortality and for the development of accelerated allograft vasculopathy after cardiac transplantation. These observations may have implications for the use of HCV-positive donors in heart transplant recipients Prevalence of HCV Ab seropositivity in Iran is lower than Pakistan and Taiwan, but higher than Belgium and India. Parenteral exposure is the main risk factor for the transmission of HCV infection in India and Mediterranean area (2, 57). Table 3. Prevalence of HCV Seropositivity in Different Populations of Ira
Given the complicated association between HCV infection, T2DM, and lipid levels, we conducted this large-scale community-based study to elucidate the association between seropositivity for. Correlates of HCV seropositivity among familial contacts of HCV positive patient Hepatitis C virus (HCV) has become the most significant cause of chronic liver disease of infectious etiology in the United States. The recognition that HCV can be transmitted perinatally or through blood transfusions warrants particular attention by the pediatrician. The American Academy of Pediatrics recommends screening infants born to HCV-infected mothers and persons with risk factors for. This large-scale community-based survey suggests that anti-HCV seropositivity is more prevalent among subjects with T2DM and non-hyperlipidemia. However, anti-HCV-positive status was not. Hepatitida C je infekční onemocnění, které postihuje především játra.Toto onemocnění způsobuje virus hepatitidy C (HCV). Hepatitida C často není doprovázena žádnými příznaky, chronická infekce však může vést ke zjizvení jater a po mnoha letech až k cirhóze.V některých případech dochází u osob s cirhózou k selhání jater, rakovině jater či ke značnému.
Among 1,050 subjects, the overall prevalence of HBsAg seropositivity was 15.8%, and that of anti-HCV seropositivity was 28.9%. Intrafamilial viral transmission might be the major cause of the high prevalence of HBV infection in this region. However, HCV infection was shown to be associated with the use of inadequately sterilized medical equipment Objective: The infections caused by human immunodeficiency virus (HIV), hepatitis B (HBV) and C (HCV) viruses pose a serious occupational risk for the healthcare workers especially those in emergency services, laboratories and surgery wards. Vaccination and establishment of the strict biosafety procedures are the main principles to prevent blood-borne infections in healthcare workers Join the discussion around this anaesthesia post. Developed by doctors, MedShr is the secure and easy way to discuss anaesthesia cases with verified medical colleagues Chronic hepatitis C virus (HCV) infection is a significant burden in patients with cancer.1 Estimates of the prevalence of chronic HCV infection among patients with cancer in the United States range from 1.5% to 10.6%, and this range may be an underestimate because many cancer centers do not routinely screen patients for HCV.1 Early diagnosis with virologic cure improves liver and cancer.
HCV seropositivity was not independently associated with an increased SN risk at any site, but associated independently with reduced SN risk in Baltimore (p = 0.04) and Melbourne (p = 0.06). CONCLUSIONS: Hepatitis C (HCV) seropositivity was not associated with increased sensory neuropathy risk among HIV-positive patients at any site HCV seropositivity was assessed as an SN risk using a χ 2 test, followed by logistic regression modeling to correct for treatment exposures and demographics. Results: A total of 837 patients of African, Asian, and Caucasian descent were studied Introduction. Hepatitis C virus (HCV) is a bloodborne pathogen that is prevalent among people who have used injection drugs.1 Men who have sex with men (MSM) have also been reported to have a higher prevalence of HCV compared with the general population; in a review, the prevalence of HCV among MSM was as high as 22.7%.2 However, more recent studies have found a much lower burden (0.07-4.5%. include HCV suggested for LP, and the aim of this study was comparison of seropositivity of HCV in LP patients and control group. Methods: Total of oral LP patients that refer to dermatology clinic in farshchian hospital entered to study. Five cc clot blood took fro Beenu Thakral, Neelam Marwaha, Y. K. Chawla, Karan Saluja, Arpita Sharma, R. R. Sharma, R. W. Minz, S. K. Agnihotr
Current Prevalence of HBV and HCV Seropositivity: The Initiative for Attentiveness and Deterrence of Viral Hepatitis in the Qassim Region of Saudi Arabia. Ahmed N Aljarbou. Background: The spread of hepatitis B virus (HBV) and hepatitis C virus (HCV) continues at an alarming worldwide In 2016, WHO passed the Global Health Sector Strategy on Viral Hepatitis (GHSS), calling for its elimination by 2030. Two years later, Turkey approved a strategy to reach the WHO targets. This study reports new national prevalence data, breaks it down by subpopulation, and models scenarios to reach HCV elimination. Literature was reviewed for estimates of HCV disease burden in Turkey Prevalence and Factors Associated with HCV (Hepatitis C Virus) Seropositivity in Islamabad, Pakistan Hammad Ali Qazi, Khalid Saleem, Iqbal Mujtaba, Anjum Hashmi, Jamil Ahmed Soomro; Affiliations Hammad Ali Qazi College of Physicians and Surgeons Pakistan. Khalid Saleem PINSTECH Complex Hospital, Pakistan.. The distribution of seropositivity for HBsAg and anti-HCV antibody varies by the department of sample origin. The medicine ward show the highest seropositivity rates for both HBsAg (9.81%) and HCV (4.24%) while lowest seropositivity rate for HBsAg was seen in gynaecological patients (2.70%) and for HCV infection in paediatrics patients (0.85%)
The small body of studies of HCV among FSW has documented exposure but not current infection. Studies have shown lower anti-HCV prevalence ranging from 2.6% in India to 12% in China, Taiwan. 12,13 In contrast, a more recent study in Canada found higher anti-HCV seropositivity (42.5%) among FSW. 1 HIV HCV 3.7M HIV tests (0.7% seropositivity) 1.3M HCV Ab tests (6.0% seropositivity) Reducing Disparities Addressing differences in healthcare that are closely linked with social or economic disadvantages Improving Access Enabling access to care that achieves the best health outcomes Advancin The aim of this study was to investigate seropositivity of HBsAg, Anti-HBs, Anti-HCV and Anti-HIV in the patients who were admitted to Artvin State Hospital between October 2009 and October 2012. Materials and Methods: Blood samples from the patients are analysed in Abbot Architect İ 1000 (Abbott Laboratories, İllinois,USA) using. seropositive: [ se″ro-poz´ĭ-tiv ] showing positive results on serologic examination; showing a high level of antibody Berry, N.; Chakravarty, A.; Das, U. P.; Kar, P.; Das, B. C.; Mathur, M. D. (1999) HCV seropositivity and infection of HCV in cirrhosis Diagnostic Microbiology and.
Results HbsAg and anti-HCV seropositivity rates were 5.1% and 3.2% in diabetic patients and were 3.8% and 1.3% in control group, respectively. There was no statistically significant difference between the 2 groups with respect to either marker. Shared risk factors for both hepatitis infections were increased aminotransferase levels and history of hospital admission This demonstrates that HCV seropositivity as well as HIV-1 treatment change (p=0.029) and use of antiretroviral therapy before HAART (p=0.039) were independently associated with a smaller increase in CD4-cell count after the start of HAART, while suppression of viral load below 400 HIV-1 RNA copies/mL (p<0.001) was an independent predictor of. The present meta-analysis was conducted to evaluate the strength and the consistency of the association between hepatitis C virus (HCV) infection and non-Hodgkin lymphoma (NHL) and other lymphoid neoplasms. Only studies with ≥100 cases which were also adjusted for sex and age were included. Fifteen case-control studies and three prospective studies contributed to present analysis, nine of. Comparison of seropositivity of HIV, HBV, HCV and syphilis in replacement and voluntary blood donors in western India. Indian Journal of Pathology & Microbiology. 2001 Oct; 44(4): 409-12 Abstract
collected from Pulmonology ward showed less seropositivity for HBV and HCV ( =03 ,.% )markers(Table ). Viral hepatitis is a major health problem worldwide. HBV and HCV are becoming endemic for the entire world. HBV and HCV cause coinfection due to the same transmission mode [ ,]. Investigating the coinfection HBV and HCV is crucia The rate of HCV seropositivity was lower in Group A (4.4%), whereas it was significantly higher in the ISDAU group than ISDU group (42.3% vs 30.0%, p = 0.02). The rates of significant fibrosis and severe fibrosis were higher in Group A (34% and 21%) and the ISDAU group (29% and 18%). Seropositivity of HCV and HBV was also significantly increased among 1840 years of age group (P < 0.001). Overall age group of 1840 years was found to be common significant risk group for all the three types of infections analysed. Younger age as a risk group wa